FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

MPRX, Inc. dba Medical Park Pharmacy Naltrexone 4 Recall

Naltrexone 4

MPRX, Inc. dba Medical Park Pharmacy · Dallas, TX

Risk level
Class II
Reported by FDA
Feb 5, 2020
Recall ID
D-0810-2020
Check your lot numberHow we source this data

Summary

MPRX, Inc. dba Medical Park Pharmacy recalled Naltrexone 4 starting Dec 18, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0810-2020 on Feb 5, 2020. Reason: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components. Status: Terminated.

Why it was recalled

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Product description

Naltrexone 4.5 mg capsule

Lot numbers, UPCs & expiration codes

Lot: 60564:42 Use by: 02/10/2020

Where it was sold

TX

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0810-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 18, 2019
FDA report date
Feb 5, 2020
Quantity
2 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
MPRX, Inc. dba Medical Park Pharmacy

Original FDA data

Every field from FDA enforcement report D-0810-2020, exactly as published.

Show all FDA fields
City
Dallas
State
TX
Status
Terminated
Country
United States
Event ID
84527
Address
8230 Elmbrook Dr Ste 600b
Code information
Lot: 60564:42 Use by: 02/10/2020
Postal code
75247-4144
Report date
Feb 5, 2020
Product type
Drugs
Recall number
D-0810-2020
Classification
Class II
Recalling firm
MPRX, Inc. dba Medical Park Pharmacy
Product quantity
2 bottles
Termination date
Dec 13, 2022
Reason for recall
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Naltrexone 4.5 mg capsule
Distribution pattern
TX
Recall initiation date
Dec 18, 2019
Initial firm notification
Letter
Center classification date
Jan 29, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0810-2020, published Feb 5, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls